← Back to Search

Inhalational Analgesic

Intervention group for Acute Pain

Phase 3
Waitlist Available
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention
Awards & highlights

Study Summary

This is a randomised, double-blind, placebo controlled study to evaluate the efficacy of Methoxyflurane (Penthrox®) for the treatment of acute pain during closed nasal fracture reduction. The study aims to provide evidence under blinded controlled conditions that Penthrox is safe and effective in patients aged 18 to 65 years during closed nasal fracture reduction.

Eligible Conditions
  • Acute Pain
  • Broken Nose

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain level variation during nasal closed reduction: visual analog scale
Secondary outcome measures
Number of procedures limited by pain
Pain level during anesthesia: visual analog scale
Rate of participants requesting backup analgesia during the procedure
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention groupExperimental Treatment1 Intervention
Inhalation of Methoxyflurane through a Penthrox inhaler
Group II: Control groupPlacebo Group1 Intervention
Inhalation of placebo (0.9% salin solution) through a Penthrox inhaler

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
292 Previous Clinical Trials
69,407 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Inhaled Methoxyflurane for Pain Management in Nasal Bone Fracture Reduction
Pierre-Hugues Fortier 2019. "Inhaled Methoxyflurane for Pain Management in Nasal Bone Fracture Reduction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04332159.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top